Literature DB >> 31519794

Is "Geriatric" Assessment Just for Older Patients?

Gabriel F P Aleixo1, Seul Ki Choi2, Alyssa J Tan2, Kirsten A Nyrop3, Alyson M Deal3, William A Wood3, Trevor A Jolly3, Hyman B Muss3.   

Abstract

Geriatric assessment (GA) is used in oncology to identify deficits in older patients with cancer that may affect treatment choice. We examine GA in 550 patients with early breast cancer, including both younger (<65 years) and older women (aged 65 years or older), to assess the potential value of this tool in younger, presumed "healthier" patients. Although older women have more GA-identified deficits overall, younger patients are more anxious. Suboptimal physical function was problematic across the age spectrum. GA domains can identify major deficits in younger patients beyond those likely to be uncovered in routine investigation. © AlphaMed Press 2019.

Year:  2019        PMID: 31519794     DOI: 10.1634/theoncologist.2019-0373

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  10 in total

1.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors:  Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Falls in Older Adults With Cancer: Evaluation by Oncology Providers.

Authors:  Emily J Guerard; Allison M Deal; Grant R Williams; Trevor A Jolly; Kirsten A Nyrop; Hyman B Muss
Journal:  J Oncol Pract       Date:  2015-07-14       Impact factor: 3.840

3.  American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity.

Authors:  Lawrence H Kushi; Colleen Doyle; Marji McCullough; Cheryl L Rock; Wendy Demark-Wahnefried; Elisa V Bandera; Susan Gapstur; Alpa V Patel; Kimberly Andrews; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012 Jan-Feb       Impact factor: 508.702

4.  Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer.

Authors:  Emily J Guerard; Allison M Deal; YunKyung Chang; Grant R Williams; Kirsten A Nyrop; Mackenzi Pergolotti; Hyman B Muss; Hanna K Sanoff; Jennifer L Lund
Journal:  J Natl Compr Canc Netw       Date:  2017-07       Impact factor: 11.908

Review 5.  Geriatric assessment in oncology practice.

Authors:  Arti Hurria
Journal:  J Am Geriatr Soc       Date:  2009-11       Impact factor: 5.562

6.  Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Authors:  Trevor A Jolly; Allison M Deal; Kirsten A Nyrop; Grant R Williams; Mackenzi Pergolotti; William A Wood; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Susan G Moore; W Chris Taylor; Michael Messino; Hyman B Muss
Journal:  Oncologist       Date:  2015-03-12

7.  Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors.

Authors:  Tomohiro F Nishijima; Allison M Deal; Grant R Williams; Hanna K Sanoff; Kirsten A Nyrop; Hyman B Muss
Journal:  Oncologist       Date:  2018-01-25

8.  Feasibility of geriatric assessment in community oncology clinics.

Authors:  Grant R Williams; Allison M Deal; Trevor A Jolly; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Oludamilola A Olajide; W Chris Taylor; Michael J Messino; Hyman B Muss
Journal:  J Geriatr Oncol       Date:  2014-04-03       Impact factor: 3.599

9.  Mental status evaluation in older adults with cancer: Development of the Mental Health Index-13.

Authors:  Mackenzi Pergolotti; Michelle M Langer; Allison M Deal; Hyman B Muss; Kirsten Nyrop; Grant Williams
Journal:  J Geriatr Oncol       Date:  2018-09-08       Impact factor: 3.599

10.  Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

Authors:  Ethan Basch; Amylou C Dueck; Lauren J Rogak; Sandra A Mitchell; Lori M Minasian; Andrea M Denicoff; Jennifer K Wind; Mary C Shaw; Narre Heon; Qian Shi; Brenda Ginos; Garth D Nelson; Jeffrey P Meyers; George J Chang; Harvey J Mamon; Martin R Weiser; Tatjana Kolevska; Bryce B Reeve; Deborah Watkins Bruner; Deborah Schrag
Journal:  J Clin Oncol       Date:  2018-09-11       Impact factor: 44.544

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.